It can inhibit the synthesis of prostaglandins and has antipyretic and analgesic effects

It is an antihistamine that can relieve symptoms such as runny nose, nasal congestion, and sneezing.

In the acidic environment of the stomach, a diffuse protective layer is formed to cover the ulcer surface, preventing gastric acid, enzymes and food from invading the ulcer; it reduces the activity of pepsin, increases mucin secretion, and promotes the release of prostaglandins from the mucosa, thereby protecting the gastric mucosa; it has a killing effect on Helicobacter pylori (HP) and promotes the healing of gastritis.

The main ingredient of this product is bismuth tripotassium dicitrate. In the acidic environment of the stomach, it forms a diffuse protective layer covering the ulcer surface, preventing gastric acid, enzymes and food from invading the ulcer. This product can also reduce the activity of pepsin, increase mucin secretion, and promote the release of prostaglandins from the mucosa, thereby protecting the gastric mucosa. In addition, this product has a killing effect on Helicobacter pylori (HP), thus promoting the healing of gastritis.

The main ingredient of this product is bismuth tripotassium dicitrate. In the acidic environment of the stomach, it forms a diffuse protective layer covering the ulcer surface, preventing gastric acid, enzymes and food from invading the ulcer. This product can also reduce the activity of pepsin, increase mucin secretion, and promote the release of prostaglandins from the mucosa, thereby protecting the gastric mucosa. In addition, this product has a killing effect on Helicobacter pylori (HP), thus promoting the healing of gastritis.

This product can inhibit the synthesis of prostaglandins and has antipyretic, analgesic and anti-inflammatory effects.

This product is a fluoroquinolone antibacterial drug with a broad-spectrum antibacterial effect, especially high antibacterial activity against aerobic Gram-negative bacteria. It has good antibacterial activity against the following bacteria in vitro: most bacteria of the Enterobacteriaceae family, including Citrobacter, Enterobacter cloacae, Enterobacter aerogenes and other Enterobacter species, Escherichia coli, Klebsiella, Proteus, Salmonella, Shigella, Vibrio, Yersinia, etc. Norfloxacin also has antibacterial activity against multi-drug resistant bacteria in vitro. It also has good antibacterial effects on penicillin-resistant Neisseria gonorrhoeae, Haemophilus influenzae and Moraxella catarrhalis. Norfloxacin is a bactericide that acts on the A subunit of bacterial DNA helicase, inhibiting DNA synthesis and replication, leading to bacterial death.

This product belongs to the macrolide antibiotics. It inhibits bacterial protein synthesis by binding to the 50S subunit of the ribosome of sensitive bacteria. It has antibacterial activity against Staphylococcus (except methicillin-resistant strains), all groups of streptococci and Gram-positive bacilli. Streptococcus pyogenes, group A hemolytic streptococci, Staphylococcus, Streptococcus pneumoniae, meningococci, gonorrhea, Bordetella pertussis, etc. are also sensitive to this product. This product also has antibacterial effects on various anaerobic bacteria except Bacteroides fragilis and Fusobacterium. It also has inhibitory effects on Mycoplasma pneumoniae, Chlamydia, Legionella, Treponema pallidum, Leptospira, and Campylobacter fetus.